Shares of Bausch Health are off earlier lows following the stock resuming trading, though remain down $1.28, or 17%, at $6.30. Following a halt for news, Bausch Health said it was aware of a news article issued by Reorg today, citing unnamed sources. The company said in a statement: “The article contains unsubstantiated rumors, including that the Company is considering a bankruptcy or insolvency proceeding of any kind – it is not.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Bausch Health Refutes Bankruptcy Rumors
- Bausch Health Announces New CFO and Executive Compensation Plan
- Bausch initiated with Market Perform on Xifaxan risk at Raymond James
- Bausch Health initiated with a Market Perform at Raymond James
- Bausch Health call volume above normal and directionally bullish